Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.
作者信息
Charteris D G
机构信息
Vitreoretinal Unit, Moorfields Eye Hospital, London.
出版信息
Br J Ophthalmol. 1995 Oct;79(10):953-60. doi: 10.1136/bjo.79.10.953.
Abstract
摘要
相似文献
1
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.增殖性玻璃体视网膜病变：病理生物学、手术治疗及辅助治疗
Br J Ophthalmol. 1995 Oct;79(10):953-60. doi: 10.1136/bjo.79.10.953.
2
[Pharmacological adjuvants for surgical treatment of proliferative vitreoretinopathy].[用于增殖性玻璃体视网膜病变手术治疗的药理学佐剂]
J Fr Ophtalmol. 2004 Nov;27(9 Pt 1):1051-9. doi: 10.1016/s0181-5512(04)96264-x.
3
Adjunctive therapies for proliferative vitreoretinopathy.增生性玻璃体视网膜病变的辅助治疗
Int Ophthalmol Clin. 2004 Summer;44(3):1-10. doi: 10.1097/00004397-200404430-00003.
4
Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.玻璃体内注射结晶皮质醇作为增殖性玻璃体视网膜病变的辅助治疗
Br J Ophthalmol. 2000 Sep;84(9):1064-7. doi: 10.1136/bjo.84.9.1064.
5
Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology.增殖性玻璃体视网膜病变——辅助治疗及视网膜病理学的进展
Eye (Lond). 2002 Jul;16(4):369-74. doi: 10.1038/sj.eye.6700194.
6
Proliferative vitreoretinopathy: developments in pathogenesis and treatment.增殖性玻璃体视网膜病变：发病机制与治疗的进展
Compr Ophthalmol Update. 2006 Jul-Aug;7(4):179-85.
7
[Proliferative vitreoretinopathy].[增殖性玻璃体视网膜病变]
Oftalmologia. 2004;48(3):6-10.
8
[Present state of the development and clinical use of dyes and staining substances for vitreoretinal surgery].
Klin Monbl Augenheilkd. 2009 Apr;226(4):220-3. doi: 10.1055/s-0028-1109287. Epub 2009 Apr 21.
9
[Dyes in vitreoretinal surgery].
Ophthalmologe. 2009 Jan;106(1):6. doi: 10.1007/s00347-008-1852-6.
10
[Bioactive substances in the regulation of vitreoretinal proliferation].[生物活性物质在玻璃体视网膜增殖调控中的作用]
Vestn Oftalmol. 1995 Jul-Sep;111(3):31-3.
引用本文的文献
1
Assessment of the transscleral removal technique for subretinal proliferative tissues during vitrectomy for rhegmatogenous retinal detachment.孔源性视网膜脱离玻璃体切除术中经巩膜视网膜下增殖组织切除技术的评估
Jpn J Ophthalmol. 2025 Jan;69(1):66-73. doi: 10.1007/s10384-024-01143-6. Epub 2025 Jan 23.
2
Proliferative Vitreoretinopathy in Retinal Detachment: Perspectives on Building a Digital Twin Model Using Nintedanib.增殖性玻璃体视网膜病变在视网膜脱离中的作用：使用尼达尼布构建数字孪生模型的视角。
Int J Mol Sci. 2024 Oct 15;25(20):11074. doi: 10.3390/ijms252011074.
3
In-silico screening of phytomolecules against multiple targets for wound management.针对伤口管理的多种靶点对植物分子进行计算机模拟筛选。
In Silico Pharmacol. 2024 Mar 26;12(1):19. doi: 10.1007/s40203-024-00194-4. eCollection 2024.
4
Proliferative vitreoretinopathy: an update on the current and emerging treatment options.增殖性玻璃体视网膜病变：当前和新兴治疗选择的最新进展。
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):679-687. doi: 10.1007/s00417-023-06264-1. Epub 2023 Oct 16.
5
A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study.一项辅助曲安奈德治疗开放性眼外伤玻璃体视网膜手术的随机对照试验 - ASCOT 研究。
Health Technol Assess. 2023 Jul;27(12):1-50. doi: 10.3310/GNBJ1387.
6
Proliferative Vitreoretinopathy: A Reappraisal.增殖性玻璃体视网膜病变：重新评估
J Clin Med. 2023 Aug 14;12(16):5287. doi: 10.3390/jcm12165287.
7
Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.血小板衍生生长因子受体 β 的配体非依赖性激活促进了视网膜色素上皮细胞的玻璃体诱导收缩。
BMC Ophthalmol. 2023 Aug 3;23(1):344. doi: 10.1186/s12886-023-03089-8.
8
Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy.玻璃体切除术联合硅油填充及单剂量玻璃体内注射甲氨蝶呤治疗伴有增殖性玻璃体视网膜病变的复发性视网膜脱离
Case Rep Ophthalmol. 2022 Oct 10;13(3):777-782. doi: 10.1159/000526091. eCollection 2022 Sep-Dec.
9
miRNA-124 regulates palmitic acid-induced epithelial-mesenchymal transition and cell migration in human retinal pigment epithelial cells by targeting LIN7C.微小RNA-124通过靶向LIN7C调控棕榈酸诱导的人视网膜色素上皮细胞上皮-间质转化及细胞迁移。
Exp Ther Med. 2022 Jun 1;24(1):481. doi: 10.3892/etm.2022.11408. eCollection 2022 Jul.
10
Heavy Silicone Oil as an Endotamponade in Recurrent or Complicated Retinal Detachment and Macular Hole.重硅油作为复发性或复杂性视网膜脱离伴黄斑裂孔的眼内填塞物。
Turk J Ophthalmol. 2022 Apr 28;52(2):119-124. doi: 10.4274/tjo.galenos.2021.83648.
本文引用的文献
1
Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells.巨大视网膜裂孔手术中的冷冻疗法与视网膜色素上皮活细胞的玻璃体内扩散。
Ophthalmology. 1993 Apr;100(4):466-70. doi: 10.1016/s0161-6420(93)31620-9.
2
Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.视黄酸在增殖性玻璃体视网膜病变动物模型玻璃体内硅油中的抗增殖作用。
Invest Ophthalmol Vis Sci. 1993 Mar;34(3):522-30.
3
Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.增生性玻璃体视网膜病变患者玻璃体液和视网膜下液细胞中的生长因子
Ophthalmic Res. 1993;25(1):52-9. doi: 10.1159/000267221.
4
Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.在增生性玻璃体视网膜病变中，从可生物降解聚合物微球持续释放视黄酸。
Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2743-51.
5
Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens.增殖性玻璃体视网膜病变：淋巴细胞、黏附分子及HLA - DR抗原参与情况的研究
Graefes Arch Clin Exp Ophthalmol. 1993 Jun;231(6):331-6. doi: 10.1007/BF00919029.
6
Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations.增殖性玻璃体视网膜病变和增殖性糖尿病视网膜病变中的巨噬细胞：亚群的分化
Br J Ophthalmol. 1993 Nov;77(11):731-3. doi: 10.1136/bjo.77.11.731.
7
Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group.在患有严重增生性玻璃体视网膜病变的眼中使用硅油或长效气体进行松解性视网膜切开术。硅油研究报告5。硅油研究组。
Am J Ophthalmol. 1993 Nov 15;116(5):557-64. doi: 10.1016/s0002-9394(14)73196-4.
8
Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy.
Retina. 1993;13(3):245-50. doi: 10.1097/00006982-199313030-00011.
9
Sophisticated vitreoretinal surgery in patients with a healthy fellow eye. An 11-year retrospective study.
Graefes Arch Clin Exp Ophthalmol. 1993 Sep;231(9):495-9. doi: 10.1007/BF00921113.
10
Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.通过眼内更昔洛韦缓释制剂控制巨细胞病毒性视网膜炎
Arch Ophthalmol. 1993 Feb;111(2):223-7. doi: 10.1001/archopht.1993.01090020077027.
Zotero 插件